Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA damage enables p73.

× No keyword cloud information.

12 in total

1. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors: C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal: Mol Cell Biol Date: 2001-03 Impact factor: 4.272

2. c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency.

Authors: Y E Whang; C Tran; C Henderson; R G Syljuasen; N Rozengurt; W H McBride; C L Sawyers
Journal: Proc Natl Acad Sci U S A Date: 2000-05-09 Impact factor: 11.205

Review 3. The role of p53 in human cancer.

Authors: D Malkin
Journal: J Neurooncol Date: 2001-02 Impact factor: 4.130

4. p63 and p73 in tumor suppression and promotion.

Authors: Frank D McKeon
Journal: Cancer Res Treat Date: 2004-02-29 Impact factor: 4.679

5. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria.

Authors: Olav Gressner; Tobias Schilling; Katja Lorenz; Elisa Schulze Schleithoff; Andreas Koch; Henning Schulze-Bergkamen; Anna Maria Lena; Eleonora Candi; Alessandro Terrinoni; Maria Valeria Catani; Moshe Oren; Gerry Melino; Peter H Krammer; Wolfgang Stremmel; Martina Müller
Journal: EMBO J Date: 2005-06-09 Impact factor: 11.598

Review 6. p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.

Authors: Xiaohua Su; Deepavali Chakravarti; Elsa R Flores
Journal: Nat Rev Cancer Date: 2013-02 Impact factor: 60.716

7. Mutation analysis of the p73 gene in nonastrocytic brain tumours.

Authors: M E Alonso; M J Bello; P Gonzalez-Gomez; J Lomas; D Arjona; J M de Campos; M E Kusak; J L Sarasa; A Isla; J A Rey
Journal: Br J Cancer Date: 2001-07-20 Impact factor: 7.640

8. Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone.

Authors: Kemal Alpay; Mehdi Farshchian; Johanna Tuomela; Jouko Sandholm; Kaappo Aittokallio; Elina Siljamäki; Marko Kallio; Veli-Matti Kähäri; Sakari Hietanen
Journal: PLoS One Date: 2014-08-22 Impact factor: 3.240

9. The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors: Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal: BMC Cancer Date: 2009-08-12 Impact factor: 4.430

10. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

Authors: Francesca Cottini; Teru Hideshima; Chunxiao Xu; Martin Sattler; Martina Dori; Luca Agnelli; Elisa ten Hacken; Maria Teresa Bertilaccio; Elena Antonini; Antonino Neri; Maurilio Ponzoni; Magda Marcatti; Paul G Richardson; Ruben Carrasco; Alec C Kimmelman; Kwok-Kin Wong; Federico Caligaris-Cappio; Giovanni Blandino; W Michael Kuehl; Kenneth C Anderson; Giovanni Tonon
Journal: Nat Med Date: 2014-05-11 Impact factor: 53.440